News

STADA to Become a Major Pharma Player in Ukraine by Acquiring Biopharma’s Pharmaceutical Prescription and Consumer Health Business

• STADA makes one of the largest financial investments in the Ukrainian pharmaceutical sector to date and one of the biggest business investments in Ukraine recently.
• Biopharma’s pharmaceutical business will become an integral part of STADA’s Ukrainian organization and has strong growth potential in high-quality prescription and consumer healthcare products.
• STADA CEO Peter Goldschmidt: “With this acquisition, we will become an important player in the Ukrainian pharma market with a strong local production footprint.”

Horizon Capital’s EEGF II fully exits Purcari Wineries, generating 3.3x cash-on-cash

Horizon Capital, a leading private equity firm in the region, announced today that its $370 million EEGF II fund has sold the remaining 22.7% stake held in Purcari Wineries PLC (“Purcari”, the “Company”), after successfully listing Purcari on the Bucharest Stock Exchange last year.  EEGF II has realized a 3.3 times blended gross cash-on-cash return on the exit of its holdings in Purcari.

Biopharma has launched a state-of-the-art $75 million plasma fractionation plant in Ukraine

Biopharma, a top-ten pharmaceutical producer in Ukraine specializing in plasma-based, recombinant and other drugs, has officially opened its innovative fractionator in Bila Tserkva (Kyiv region), the only biopharmaceutical plant of its kind in Eastern Europe and the near region. There are no plasma fractionation plants in any neighboring countries – the closest are in Austria, South Africa and China.  This unique plasma fractionation technology enables the plasma component of human blood to be processed to extract life-saving drugs, requires advanced research and development, GMP-certified equipment and facilities, and investments exceeding $75 million.

Dobrobut attracts investment from Horizon Capital’s new fund EEGF III

Horizon Capital, a U.S. private-equity firm investing in high growth companies in Ukraine and the near region, and Dobrobut, the leading private healthcare services provider in Ukraine, have announced that Horizon Capital’s latest $200 million fund, Emerging Europe Growth Fund III, LP (EEGF III) has acquired a minority stake in Dobrobut. Financial details for this transaction have not been disclosed.

Ajax Systems attracts $10 million investment from Horizon Capital’s new fund EEGF III

Horizon Capital, a U.S. private-equity firm investing in high growth export-oriented and domestic companies in Ukraine and the near region, and Ajax Systems, a leading producer of smart security systems in Ukraine, have announced that Horizon Capital’s latest $200 million fund, Emerging Europe Growth Fund III, LP (EEGF III) has acquired a minority stake in the Company for $10 million.

Horizon Capital hits hard cap with $200m for its third Ukraine-focused fund, the largest fund raised for Ukraine in a decade

Horizon Capital, a U.S. private-equity firm investing in high growth and export-driven companies in Ukraine and the near region, has closed its third fund, Emerging Europe Growth Fund III, L.P. (“EEGF III”, the “Fund”), at its $200 million hard cap, far surpassing the $150 million target.  In what marks the largest private equity fund raised for Ukraine in a decade, Horizon’s EEGF III received strong backing from existing and new investors, attracted by the excellent value, fast growth and abundance of opportunities that Ukraine offers. Led by Founding Partners Lenna Koszarny and Jeffrey C. Neal and Senior Partner Denis Tafintsev, Horizon manages over $850 million in assets from investors with a capital base exceeding $350 billion.  Its Ukraine-focused funds have invested over $650 million in 140 companies employing over 46,000 people.

Rozetka and EVO merge to create Ukraine’s e-commerce champion

Rozetka, the leading online e-commerce retailer in Ukraine and EVO, the internet company behind the country’s largest marketplace Prom.ua, have completed a merger, cementing their top position in Ukraine’s fast-growing e-commerce segment of the retail market.

Horizon Capital Exited Ergopack to Sarantis

Horizon Capital announced today the exit of its full stake in Ergopack, a leading Ukrainian manufacturer of household goods, to Sarantis, a European strategic investor and leading publicly-listed consumer goods company.

Horizon Capital backs the successful IPO of Purcari Wineries in Bucharest

Horizon Capital, a leading private equity firm in the region, announced today that Purcari Wineries PLC (Purcari) has completed its Initial Public Offering and commenced trading on the Bucharest Stock Exchange (BSE: WINE). The offering was well received, with retail investors oversubscribing more than four times over, despite heavy turbulence on global markets as the Dow recorded its two largest point-drops on record. As a result of this successful public launch, Horizon Capital, on behalf of its fund EEGF II, has sold a 40.9% stake in Purcari, realizing a 3.2 times gross cash-on-cash return on the sale of these shares. Horizon Capital remains an active shareholder with a 22.7% stake held, aiming to further capitalize on the fast growth of the Company, as Purcari seeks to become the undisputed champion of the high-growth CEE wine market.

Horizon Capital Increases Its Stake in Datagroup to Over 70%

Horizon Capital announced today that it has increased its stake in Datagroup, a leading independent telecom operator in Ukraine, from significant minority to over 70%. Following completion of this transaction, Horizon Capital has assumed operational control of the company. The financial details of the transaction were not disclosed.